Trials / Completed
CompletedNCT03455907
Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian, Colorectal or Bronchopulmonary Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers. The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.
Conditions
Timeline
- Start date
- 2018-01-03
- Primary completion
- 2019-01-31
- Completion
- 2019-01-31
- First posted
- 2018-03-07
- Last updated
- 2020-08-20
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03455907. Inclusion in this directory is not an endorsement.